Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  IntriCon Corporation    IIN

INTRICON CORPORATION

(IIN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/30/2020 12/01/2020 12/02/2020 12/03/2020 12/04/2020 Date
17.34(c) 17.37(c) 17.43(c) 17.21(c) 18.32(c) Last
19 784 19 170 30 067 28 533 29 655 Volume
-3.93% +0.17% +0.35% -1.26% +6.45% Change
More quotes
Financials (USD)
Sales 2020 99,8 M - -
Net income 2020 -3,25 M - -
Net Debt 2020 - - -
P/E ratio 2020 -50,0x
Yield 2020 -
Sales 2021 119 M - -
Net income 2021 3,17 M - -
Net Debt 2021 - - -
P/E ratio 2021 54,4x
Yield 2021 -
Capitalization 164 M 164 M -
Capi. / Sales 2020 1,64x
Capi. / Sales 2021 1,38x
Nbr of Employees 780
Free-Float 92,2%
More Financials
Company
IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value... 
More about the company
Notations Surperformance© of IntriCon Corporation
Trading Rating : Investor Rating :
More Ratings
All news about INTRICON CORPORATION
11/10INTRICON : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
11/09INTRICON CORP : Results of Operations and Financial Condition, Regulation FD Dis..
AQ
11/09INTRICON : Reports Third Quarter 2020 Results
AQ
11/09Intricon Reports Third Quarter 2020 Results
GL
11/04INTRICON : to Present at the Virtual 2020 Stifel Healthcare Conference
AQ
11/04IntriCon to Present at the Virtual 2020 Stifel Healthcare Conference
GL
11/02INTRICON CORP : Change in Directors or Principal Officers, Financial Statements ..
AQ
10/26INTRICON CORP : Entry into a Material Definitive Agreement, Change in Directors ..
AQ
10/26INTRICON : to Announce 2020 Third-Quarter Results on Monday, November 9, 2020
AQ
10/26IntriCon to Announce 2020 Third-Quarter Results on Monday, November 9, 2020
GL
09/11INTRICON CORP : Change in Directors or Principal Officers (form 8-K)
AQ
08/10INTRICON : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/10INTRICON CORP : Results of Operations and Financial Condition, Regulation FD Dis..
AQ
08/10IntriCon Reports Second Quarter 2020 Results
GL
07/27IntriCon to Announce 2020 Second-Quarter Results on Monday, August 10, 2020
GL
More news
News in other languages on INTRICON CORPORATION
2018INTRICON CORPORATION : publication des résultats annuels
2018INTRICON CORPORATION : Veröffentlichung des Jahresergebnisses
More news
Chart INTRICON CORPORATION
Duration : Period :
IntriCon Corporation Technical Analysis Chart | IIN | US46121H1095 | MarketScreener
Technical analysis trends INTRICON CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 23,67 $
Last Close Price 18,32 $
Spread / Highest target 52,8%
Spread / Average Target 29,2%
Spread / Lowest Target 9,17%
EPS Revisions
Managers
NameTitle
J. Scott Longval President, Chief Executive Officer, CFO & Director
Philip Irving Smith Chairman
Annalee Lutgen Finance Director & Treasurer
Doug Pletcher Vice President-Medical Business Development
Mark Stephen Gorder Director
Sector and Competitors
1st jan.Capitalization (M$)
INTRICON CORPORATION1.78%164
ABBOTT LABORATORIES24.22%184 876
MEDTRONIC PLC0.35%152 681
BECTON, DICKINSON AND COMPANY-10.74%70 408
HOYA CORPORATION23.88%46 370
ALIGN TECHNOLOGY, INC.86.97%41 138